Study of the constrictor properties of the neobladder under the influence of new chemical compounds in vivo experiment




cystectomy, ileocystoplasty, constrictor properties, new chemical compounds, nivalin, artificial bladder, enterocystometry


The orthotopic ileocystoplasty is the most preferred urine derivation method for patients after removal of the bladder. The best quality of life, self-esteem, cosmetic appearance of one’s own body, and the possibility of physiological urination characterize the artificial bladder as the “gold standard” of urine derivation. There are a greater number of postoperative complications associated with the functionality of the neobladder, considering the complexity of orthotopic derivation of urine. The autocaturation is required in some patients day or night urinary incontinence, and in the other group, periodic urinary retention. Urinary retention is more common in women up to 43 % compared with 20 % in men, who need intermittent catheterization.

The aim of investigation was to evaluate the possibility of pharmacological correction of contractile activity of mini-pigs neobladder in vivo, under the influence of new chemical compounds and the anticholinesterase drug nivalin.

Materials and methods Experimental studies were performed on 21 female mini-pigs, with an average age of 6 to 14 months. The duration of the experiment was 12 months. Performing of enterocystometry in experimental animals is possible only under anesthesia and, accordingly, only part of the urodynamic parameters can be obtained.

Results. The obtained results of in vivo experimental studies demonstrated the constrictor activity of the studied new chemical compounds. Compound I in comparison with the control group statistically significantly increased basal tone by 62.09 %, the amplitude of contractions by 37.34 %, and the duration of contractions by 35.71 %. The new chemical compound II, in comparison with the control group, showed less pronounced results of constrictor activity, so the basal tone statistically significantly increased by 38.86 %, and the amplitude of contractions by 15.0 %.

Conclusion. Thus, under the influence of new chemical compounds in the conditions of an experimental artificial bladder, constrictor properties are proved, which require further research and study. In turn, cholinomimetic nivalin has prospects for use in urology, in particular in patients with hypoactive forms of artificial and neurogenic bladder.


Khetrapal P., Conroy S., Kelly J.D., Catto J.W.F. Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence. Curr Opin Urol. 2020. Vol. 30, No. 3. P. 400–406. Doi: 10.1097/MOU.0000000000000755.

Cai P.Y., Khan A.I., Shoag J.E., Scherr D.S. Robotic Radical Cystectomy in the Contemporary Management of Bladder Cancer. Urol Clin North Am. 2021. V ol. 48, No. 1. P. 45–50. Doi: 10.1016/j.ucl.2020.09.003.

Ghosh A., Somani B. Recent trends in postcystectomy health-related quality of life (QoL) favours neobladder diversion: Systematic review of the literature. Urology. 2016. Vol. 93. P. 22–26. Doi: 10.1016/j.urology.2015.12.079.

Lee R., Abol-Enein H., Artibani W. et al. Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes. BJU Int. 2014. Vol. 113. P. 11–23. Doi: 10.1111/bju.12121.

Gacci M., Saleh O., Cai T. et al. Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. Health Qual Life Outcomes. 2013. Vol. 11. P. 43. Doi: 10.1186/1477-7525-11–43.

Cerruto M., D’Elia C., Siracusano S. et al. Systematic review and meta-analysis of non-RCTs on health-related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder vs. ileal conduit. Eur J Surg Oncol. 2016. Vol. 42. P. 343–360. Doi: 10.1016/j.ejso.2015.10.001.

Kanno T., Ito K., Sawada A. et al. Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort. Int J Urol. 2019. Vol. 26, No. 4. P. 493–498. Doi: 10.1111/iju.13917.

Rodrнguez Faba O., Parada Moreno R., Malca L., Palomino Martнnez A., Nervo N., Breda A., Esquinas C., Palou J. Postoperative management of radical cystectomy. Review of the evidence on the prevention and treatment of urological complications. Actas Urol Esp (engl ed.). 2018. Vol. 42, No. 3. P. 143–151. Doi: 10.1016/j.acuro.2017.04.006.

Akand M., Kilic O., Bocu K., Harmankaya I., Aydogan F.M. First experience with a new form of orthotopic ileal neobladder (Leuven N-Pouch) following radical cystectomy. Turk J Urol. 2019. Vol. 45, P. 150–155. Doi: 10.5152/tud.2019.68704.

Hirobe M., Tanaka T., Shindo T. et al. Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan. Int J Clin Oncol. 2018. Vol. 23, No. 4. P. 734–741. Doi: 10.1007/s10147-018-1245-z.

Ameeta L., Nayak B., Cagiannos I. et al. Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction. Can Urol Assoc J. 2018. Vol. 12. P. 181–186. Doi: 10.5489/cuaj.4877.

Lee R., Abol-Enein H., Artibani W. et al. Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes. BJU Int. 2014. Vol. 113, No. 1. P. 11–23. Doi: 10.1111/bju.12121.

Nagele U., Kuczyk M., Anastasiadis A.G. Radical Cystectomy and Orthotopic Bladder Replacement in Females. Eur. Urol. 2006. Vol. 50. P. 249–257. Doi: 10.1016/j.eururo.2006.05.037.

Studer U., Burkhard F., Schumacher M., Kessler T. et al. Twenty Years Experience With an Ileal - Orthotopic Low Pressure Bladder Substitute - Lessons to be Learned. J. Urol. 2006. Vol. l76. P. 161–166. Doi: 10.1016/S0022-5347(06)00573-8.

Moon A., Vasdev N., Thorpe A.C. Continent Urinary Diversion. Indian J Urol. 2013. Vol. 29(4). P. 303–309. Doi: 10.4103/0970-1591.120111.

Morrison C.D., Kielb S.J. Use of Bowel in Reconstructive Urology: What a Colorectal Surgeon Should Know. Clin Colon Rectal Surg. 2017. Vol. 30(3). P. 207–214. Doi: 10.1055/s-0037-1598162.

Savchuk R., Zhukovsky D. Regulation of the Contractile Activity of the Small Intestine Isolated Segment in Vitro. International Journal of Pharmacy and Chemistry. 2017. Vol. 3. P. 62–66. Doi: 10.11648/j.ijpc.20170305.11.

Hoag N., Tse V., Wang A., Chung E., Gani J. Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy. Int Neurourol J. 2016. Vol. 20(1). P. 81–85. Doi: 10.5213/inj.1630380.190.

El-Bahnasawy M.S., Shaaban H., Gomha M.A., Nabeeh A. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. Scand J Urol Nephrol. 2008. Vol. 42(4). P. 344–351. Doi: 10.1080/00365590701832726.

Simma-Chiang V., Ginsberg D.A., Teruya K.K., Boyd S.D. Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience. Urology. 2012. Vol. 79(6). P. 1397–1401. Doi: 10.1016/j.urology.2012.02.006.